ARK Genomic Revolution UCITS ETF Class A USD Accum

AAKG XETRA Healthcare & Biotech Monde
5.45
2.14 %

ETF focused on innovative companies in genomics, biotechnology, and health , aiming to capture the genomic revolution.

Performance & Momentum

6 Months 9.56 %
1 Year 37.33 %
3 Years 34.44 %
5 Years 35.39 %

Similar stocks to ARK Genomic Revolution UCITS ETF Class A USD Accum

Anantys Community

Be the first to share your analysis on ARK Genomic Revolution UCITS ETF Class A USD Accum.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases